<DOC>
	<DOCNO>NCT02058251</DOCNO>
	<brief_summary>In comparison general population , military personnel veteran increase risk develop substance use disorder ( SUDs ) post-traumatic stress disorder ( PTSD ) . Despite promising development past decade , treatment patient SUDs comorbid PTSD woefully inadequate ( Back , 2010 ; Back et al. , 2014 ; Brady et al. , 2007 ; McCauley et al. , 2012 ) . One adverse effect abuse drug long-term negative impact social behavior think involve oxytocin ( OT ) dysregulation ( McGregor et al. , 2008 ) . In preclinical clinical experiment , local , intra-nasal , systemic OT administration decrease activation amygdala response visual fearful/threatening stimulus ( Kirsch et al. , 2005 ) , ameliorate effect stressful event , decrease drug-taking seek behavior ( McGregor et al. , 2008 ; Baskerville Douglas , 2010 ; Carson et al. , 2010a ; Bowen et al. , 2011 ; Cox et al 2013 ) . However , little attention focus whether OT decrease SUD vulnerability exposure traumatic stress preclinical clinical study . This clinical project determine whether intra-nasally administer OT decrease craving ( Aim 1 ) use alcohol decrease stress reactivity ( Aim 2 ) follow exposure laboratory-induced stress ( Trier Social Stress Task ) among veteran dual diagnosis alcohol use disorder PTSD .</brief_summary>
	<brief_title>Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Male female ; race ethnicity ; age 2165 year . Female subject require complete laboratory test early midfollicular phase menstrual cycle ( day 17 follow onset menses ) . Veteran US military ; service branch . Able provide inform consent function intellectual level sufficient allow accurate completion assessment instrument . Subjects must able comprehend English . Meet DSM5 criterion current alcohol use disorder ( assessed via Mini International Neuropsychiatric Interview ; MINI ) . Note use currently available diagnostic measure ( MINI DSMIV ) make appropriate modification update compatibility DSM5 . Meet DSM5 criterion current PTSD ( assess via Clinician Administered PTSD Scale ; CAPS ) . Note use currently available assessment instrument ( CAPS DSMIV ) , make appropriate modification update compatibility DSM5 . A CAPS score 50 great . Subjects require least 5 day abstinence alcohol substance ( except caffeine nicotine ) prior complete laboratory testing , verify multiple method include selfreport , breathalyzer test , urine drug screen test . Subjects may also meet criterion mood disorder ( except bipolar affective disorder , see Exclusion Criteria ) anxiety disorder ( e.g. , agoraphobia , social phobia , generalize anxiety disorder ) . The inclusion subject affective anxiety disorder essential mark frequency coexistence mood anxiety disorder among patient PTSD alcohol use disorder . Subjects take psychotropic medication require maintain stable dose least eight week study initiation . This initiation change psychotropic medication course trial may interfere interpretation result . Must consent random assignment oxytocin placebo . Subjects meet DSM5 criterion history current psychotic bipolar affective disorder , current suicidal homicidal ideation intent . Those subject refer clinically . Subjects would present serious suicide risk likely require hospitalization course study . Those subject refer clinically . Subjects maintenance anxiolytic , antidepressant , mood stabilize medication , initiate past 8 week . Subjects history major medical illness ( e.g. , endocrine , cardiovascular , central nervous system disorder , peripheral neuropathy , pulmonary disease ) acute unstable medical condition might interfere safe conduct study accurate interpretation result . Subjects meet DSM5 criterion another substance use disorder , except caffeine nicotine , within past 12 month . Subjects experience withdrawal symptom , evidence score 10 Clinical Institute Withdrawal Assessment Alcohol ( CIWA ) Females unable unwilling schedule lab test early midfollicular phase menstrual cycle . Pregnant woman exclude propose study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Alcohol</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Stress reactivity</keyword>
</DOC>